Pan-cancer microsatellite instability testing using a multiplex assay including long mononucleotide repeats. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium.

The improvement in measures of well-being over the past decade illustrates that progress is possible and should encourage the cancer care community to continue efforts to optimize oncology training.

Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study ASCO Guidelines provide recommendations with ...

Burnout in oncologists has been increasing, especially after the COVID-19 pandemic. This is concerning because burnout can have both personal and professional repercussions, as well as a negative ...

Rx for Resilience: Curing Burnout in Oncology Through Smarter Workflows and Supportive Practices If you have the appropriate software installed, you can download article citation data to the citation ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Oncologists in 2023 are experiencing higher rates of burnout compared with a decade ago. System-based interventions to reduce burnout are necessary to maintaining an adequate workforce to provide care ...

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software ...

Factors and timing of decreased adherence to S-1 in postoperative docetaxel + S-1 therapy for gastric cancer. Investigation of synergistic effects in trials of combination therapies with ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors Oncologists in 2023 are experiencing higher ...

Abbreviations: CR, complete response; ECOG, Eastern Cooperative Oncology Group; IFS, infantile fibrosarcoma; NOS, not otherwise specified; PD, progressive disease; PR ...